The ratio of ER expression in tumor vs. precancerous tissue was significantly lower in stage 4 samples as compared to stage 1 samples for all ERs: ERα66, ERα36, and ERβ (Fig. 4D, Table 2). The gene discussed is ESR1; the disease is neoplasm.